Olagunju Peter Insider Trades

Insider Trading History

Track insider trading activity for Olagunju Peter. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Jun 01, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$340k 231,363 shares
$1.47
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $145k 98,124 shares
Last Trade
Dec 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 114,478 shares
$0.97
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $35.7k 24,092 shares
Last Trade
Dec 13, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.78k 1,659 shares
$1.07
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $38.1k 25,751 shares
Last Trade
Dec 12, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.77k 1,610 shares
$1.10
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $40.5k 27,361 shares
Last Trade
Dec 09, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.76k 1,561 shares
$1.13
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $42.8k 28,922 shares
Last Trade
Dec 08, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.76k 1,410 shares
$1.25
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $44.9k 30,332 shares
Last Trade
Dec 07, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.76k 1,378 shares
$1.28
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $46.9k 31,710 shares
Last Trade
Dec 06, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.76k 1,327 shares
$1.33
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $48.9k 33,037 shares
Last Trade
Dec 05, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.77k 1,291 shares
$1.37
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $50.8k 34,328 shares
Last Trade
Dec 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.77k 1,273 shares
$1.39
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $91.8k 62,047 shares
Last Trade
Dec 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$96.2k 66,818 shares
$1.44
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $126k 84,949 shares
Last Trade
Nov 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$127k 95,456 shares
$1.33
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $0 0 shares
Last Trade
Nov 17, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$339k 254,847 shares
$1.33
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $69.7k 47,100 shares
Last Trade
Dec 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 47,100 shares
$5.21
$1.48
Tcr2 Therapeutics
Tcr2 Therapeutics TCRR
Chief Technical Officer
Holding Value $424k 286,367 shares
Last Trade
Jul 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.63M 286,367 shares
$12.69
$1.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up